Maitake-MRL 90 tab (högkvalité)
Maitake (Grifola frondosa)
(Hui Shu Hua på kinesiska, 'the laughing mushroom')
Maitake är en populär gourmetsvamp med goda egenskaper inom cancerbehandling. Precis som många andra svampar med starka anticancerogena egenskaper innehåller också G.frondosa olika betaglukan, heteropolysaccarider, proteoglycan fractions. Japanska studier har visat lovande resultat för bl a bröst, lever- lungcancer samt minskade biverkningar av kemoterapi
G frondosa har också används med god resultat vid polycystisk ovariesyndrom.
(OBS: den ersätter inte annan cancerbehandling).
Källa:: Medicinal mushrooms, A Clinical Guide, av Martin Powell
Cultivation Process of Maitake MRL™
While Mycology Research Laboratories Ltd.´s Maitake-MRL (Grifola frondosa) is not an extract of Grifola frondosa, the powder contains both mycelium and primordia (young fruit body) cultivated into a biomass that is grown on a sterilised (autoclaved) substrate.
This cultivation process ensures the powder is free from contamination by other fungi and that pesticides and heavy metals are absent.
The cultivation system is proprietary, allowing for standardised production of Grifola frondosa. The powder biomass is then sealed in plastic containers.
The Maitake-MRL biomass contains mycelium and primordia (young fruiting body) of the respective mushroom. In comparison to Maitake extracts, biomass has the advantage of no unwanted shift of effect which happens with extracts or concentrates, including lyophilisation, and thus the activity of the product corresponds with the source mushroom, while being further intensified by utilizing the entire mycelium.
Mycelium biomass of mushrooms offers a mixture of many co-operating and co-related healthful bioavailable ingredients prepared by nature itself – it is thus a truly pure natural product.
Mushrooms spend more than 90% of their life cycle in the mycelium. Since mushrooms cannot produce their own energy through photosynthesis, the mycelium must be able to actively obtain or produce extracellular compounds and metabolites that promote the longevity and vitality of the living mushroom. These properties lie behind the high enzymatic activity of the mycelium, which stays preserved in the carefully processed MRL products.
Manufacturing Process of Maitake MRL™
Our Grifola frondosa is processed under the same rigorously controlled conditions that are applied to the manufacture of a conventional pharmaceutical. This ensures that each tablet contains 500 mg of the standardised Grifola product. The tablets are film coated to protect them from moisture, thus preserving the quality of the product and ensuring a long shelf life.
After passing quality control testing the tablets are released for use. The choice of additives used in manufacture renders these tablets suitable for Kosher or vegetarian use.
The fungal biomass Grifola frondosa that comprises Maitake-MRL is certified 100% Organic in the United States by Quality Assurance International (Certificate No. 103491-A).
Chemical and Biological Properties
Each Tablet of Maitake MRL contains
|Grifola frondosa - biomass powder||500 mg|
|Vegetable Magnesium Sterate|
Maitake-MRL - Enzyme Activity Per 750 mg Tablet
|Protein content||20.2 mg|
|Reducing sugars||12.6 mg|
|Protein-bound polysaccharide||79.5 mg|
|Peroxidase activity||40.2 mU|
|Laccase activity||411.5 mU|
|Glucoamylase / glucansase activity||1.6 U|
|Protease activity||4.9 U|
|Superoxide dismutase (SOD) activity||70.2 U|
|Cytochrome P-450||0.60 nmoles|
|Cytochrome P-450 reductase||7.14 mU|
|Secondary metabolites (Thrombin inhibitors)||49%|
Disclaimer: Örtmedicin ersätter inte allopatisk behandling. Konsultera alltid din läkare